| The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative … M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ... American Journal of Transplantation 18 (2), 293-307, 2018 | 1013 | 2018 |
| The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology A Loupy, M Haas, K Solez, L Racusen, D Glotz, D Seron, BJ Nankivell, ... American journal of transplantation 17 (1), 28-41, 2017 | 706 | 2017 |
| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 524 | 2020 |
| Frailty and mortality in kidney transplant recipients MA McAdams-DeMarco, A Law, E King, B Orandi, M Salter, N Gupta, ... American journal of transplantation 15 (1), 149-154, 2015 | 332 | 2015 |
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation M Delville, TK Sigdel, C Wei, J Li, SC Hsieh, A Fornoni, GW Burke, ... Science translational medicine 6 (256), 256ra136-256ra136, 2014 | 223 | 2014 |
| Quantifying renal allograft loss following early antibody-mediated rejection BJ Orandi, EHK Chow, A Hsu, N Gupta, KJ Van Arendonk, ... American journal of transplantation 15 (2), 489-498, 2015 | 128 | 2015 |
| Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients MA McAdams-DeMarco, A Law, J Tan, C Delp, EA King, B Orandi, ... Transplantation 99 (4), 805-810, 2015 | 126 | 2015 |
| Incidence and outcomes of BK virus allograft nephropathy among ABO-and HLA-incompatible kidney transplant recipients A Sharif, N Alachkar, S Bagnasco, D Geetha, G Gupta, K Womer, L Arend, ... Clinical journal of the American Society of Nephrology 7 (8), 1320-1327, 2012 | 122 | 2012 |
| Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation BJ Orandi, AA Zachary, NN Dagher, SM Bagnasco, JM Garonzik-Wang, ... Transplantation 98 (8), 857-863, 2014 | 120 | 2014 |
| Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies G Gupta, BGA Jawdeh, LC Racusen, B Bhasin, LJ Arend, B Trollinger, ... Transplantation 97 (12), 1240-1246, 2014 | 117 | 2014 |
| Abatacept in B7-1-positive proteinuric kidney disease N Alachkar, N Carter-Monroe, J Reiser N Engl J Med. 370 (13), 1263-4, 2014 | 116* | 2014 |
| Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis EH Garin, J Reiser, G Cara-Fuentes, C Wei, D Matar, H Wang, N Alachkar, ... Pediatric Nephrology 30, 469-477, 2015 | 102 | 2015 |
| Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy N Alachkar, C Wei, LJ Arend, AM Jackson, LC Racusen, A Fornoni, ... Transplantation 96 (7), 649-656, 2013 | 79 | 2013 |
| Presentation and outcomes of C4d‐negative antibody‐mediated rejection after kidney transplantation BJ Orandi, N Alachkar, ES Kraus, F Naqvi, BE Lonze, L Lees, ... American Journal of Transplantation 16 (1), 213-220, 2016 | 77 | 2016 |
| CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease LH Mariani, AS Bomback, PA Canetta, MF Flessner, M Helmuth, ... American journal of kidney diseases 73 (2), 218-229, 2019 | 75 | 2019 |
| Hepatitis C virus and its renal manifestations: a review and update N Latt, N Alachkar, A Gurakar Gastroenterology & hepatology 8 (7), 434, 2012 | 69 | 2012 |
| Rituximab and therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis postkidney transplantation S Alasfar, D Matar, RA Montgomery, N Desai, B Lonze, V Vujjini, ... Transplantation 102 (3), e115-e120, 2018 | 66 | 2018 |
| Diabetes mellitus in the transplanted kidney V Peev, J Reiser, N Alachkar Frontiers in endocrinology 5, 109841, 2014 | 61 | 2014 |
| Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients N Alachkar, BE Lonze, AA Zachary, MJ Holechek, K Schillinger, ... Transplantation 94 (2), 165-171, 2012 | 61 | 2012 |
| Atypical hemolytic uremic syndrome recurrence after kidney transplantation D Matar, F Naqvi, LC Racusen, N Carter-Monroe, RA Montgomery, ... Transplantation 98 (11), 1205-1212, 2014 | 60 | 2014 |
Robert MontgomeryProfessor of Surgery, NYUEmail verificata su nyumc.org
